SILEXION THERAPEUTICS CORP
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | — | $7.6M | $8.3M |
| FY2023 | — | $-15.5M | $4.6M |
| FY2024 | — | $-4.0M | $1.2M |
| FY2025 | — | $2.6M | $6.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | — | $7.6M | $8.3M |
| FY2023 | — | $-15.5M | $4.6M |
| FY2024 | — | $-4.0M | $1.2M |
| FY2025 | — | $2.6M | $6.0M |